Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Sarah Cannon Research Institute (SCRI), a McKesson subsidiary, seeks a Study Activation Specialist to manage startup activities for clinical trials within the Strategic Sites program. You will coordinate across internal SC groups, Strategic Sites physicians and staff, CROs, and pharmaceutical companies, acting as the primary contact through feasibility, planning, and initiation up to site activation.
Ideal candidates have a background in healthcare or clinical trials and are skilled at building
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
People who live with cancer – those who work to prevent it, fight it and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
As the Study Activation Specialist, you are responsible for managing the startup activities of clinical trials proposed and entering those trials into the Sarah Cannon Strategic Sites’ clinical research program menus. You will maintain relationships and facilitate progress across multiple groups including but not limited to internal SC departments, Strategic Sites physicians and staff, Contract Research Organizations (CROs), and Pharmaceutical Companies. You will serve as the primary responsible party and point of contact during clinical research trial feasibility, planning, and implementation stages up until the point of site activation.
You should have for this position:
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That's why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.